Cases 61 - 70 of 108
Fresenius Kabi USA, LLC et al v. Mylan Laboratories Limited et al
as 1:2015cv00185
Plaintiff:
Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GMBH
Defendant:
Mylan Laboratories Limited, Mylan Inc., Agila Specialties Inc. and others
Cause Of Action: 35 U.S.C. § 271
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00183
Plaintiff:
Astrazeneca Pharmaceuticals LP , Astrazeneca UK Limited and AstraZeneca AB
Defendant:
Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Flamel Ireland, Ltd. v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00178
Plaintiff:
Flamel Ireland, Ltd.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan, Inc.
Cause Of Action: 35 U.S.C. § 145
Janssen Pharmaceutica, N.V. et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2015cv00152
Plaintiff:
Janssen Pharmaceutica, N.V. , Janssen Sciences Ireland UC , Gilead Sciences, Inc. and others
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_defendant:
Gilead Sciences Ireland UC , Gilead Sciences, Inc. , Janssen Pharmaceutica, N.V. and others
Cause Of Action: 35 U.S.C. § 271
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al
as 1:2015cv00149
Plaintiff:
GILEAD SCIENCES, INC. and EMORY UNIVERSITY
Defendant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Counter_defendant:
EMORY UNIVERSITY and GILEAD SCIENCES, INC.
Cause Of Action: 28 U.S.C. § 1338
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00145
Plaintiff:
Boehringer Ingelheim Pharmaceuticals, Inc. , Boehringer Ingelheim International GmbH , Boehringer Ingelheim Corporation and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Janssen Biotech, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00130
Plaintiff:
Janssen Biotech, Inc. , Janssen Oncology, Inc. and Janssen Research & Development, LLC
Defendant:
Mylan Pharmaceuticals Inc. and Mylan, Inc.
Cause Of Action: 35 U.S.C. § 271
Salix Pharmaceuticals, Inc et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2015cv00109
Plaintiff:
Salix Pharmaceuticals, Inc and Dr. Falk Pharma GmbH
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan, Inc. and Mylan Pharmaceuticals, Inc.
Counter_defendant:
Dr. Falk Pharma GmbH and Salix Pharmaceuticals, Inc
Cause Of Action: 35 U.S.C. § 271
DUCHESNAY INC. et al v. MYLAN PHARMACEUTICALS INC.
as 1:2015cv00092
Plaintiff:
DUCHESNAY INC. and DUCHESNAY USA INC.
Defendant:
MYLAN PHARMACEUTICALS INC.
Counter_claimant:
MYLAN PHARMACEUTICALS INC.
Counter_defendant:
DUCHESNAY INC.
Cause Of Action: 35 U.S.C. § 271
Takeda GMBH et al v. Mylan Pharmaceuticals Inc.
as 1:2015cv00093
Plaintiff:
Takeda GMBH , Astrazeneca Pharmaceuticals LP and Astrazeneca UK Limited
Defendant:
Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc.
Counter_defendant:
Astrazeneca Pharmaceuticals LP , Astrazeneca UK Limited and Takeda GMBH
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
